BOSTON BIOMEDICAL, INC.

Basic Information

333 PROVIDENCE HWY
NORWOOD, MA, 02062-

Company Profile

n/a

Additional Details

Field Value
DUNS: 791503456
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of Specific Gene Silencing Methods and Reagents

    Amount: $312,194.00

    DESCRIPTION (provided by applicant): RNA interference (RNAi), a potent and selective gene silencing mechanism, has revolutionized the field of biological science. The ability of RNAi to specifically d ...

    SBIR Phase I 2011 Department of Health and Human Services
  2. Development of aiRNA technology

    Amount: $485,527.00

    DESCRIPTION (provided by applicant): The discovery of RNA interference (RNAi) promises to revolutionize medicine due to its unlimited potential to treat genetic, epigenetic and infectious diseases ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Cancer targeted therapy through bacterial RNAi

    Amount: $437,294.00

    DESCRIPTION (provided by applicant): The recent discovery of RNAi has created the opportunity to develop an entirely new class of drugs against a variety of human diseases that work by silencing disea ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government